Read More
Tel Aviv startup Immunai aim to map the immune system

At-risk coronavirus patients can be identified in advance - study

The study focused on collecting information and samples from hospitalized COVID-19 patients to create a detailed profile of the immune response and to compare their different immune responses.

Israeli firm ready to assist coronavirus victims with novel drug

The innovative therapy is based on the research of Prof. Dror Mevorach, a senior physician from Hadassah-Hebrew University Hospital.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy